Vit D Supplementation Doesn't Improve Fetal, Infant Growth

Share this content:
Vit D Supplementation Doesn't Improve Fetal, Infant Growth
Vit D Supplementation Doesn't Improve Fetal, Infant Growth

THURSDAY, Aug. 9, 2018 (HealthDay News) -- Maternal vitamin D supplementation from mid-pregnancy until birth or until six months postpartum does not improve fetal or infant growth, according to a study published in the Aug. 9 issue of the New England Journal of Medicine.

Daniel E. Roth, M.D., Ph.D., from the Hospital for Sick Children in Toronto, and colleagues randomized one group of Bangladeshi women to neither prenatal nor postpartum vitamin D; this was the placebo group. Three groups of women received only prenatal supplementation (17 to 24 weeks of gestation until birth with doses of 4,200 IU, 16,800 IU, or 28,000 IU). A fifth group received prenatal supplementation as well as 26 weeks of postpartum supplementation (both 28,000 IU).

The researchers found that among 1,164 infants assessed at 1 year of age, there were no significant differences across groups in the mean length-for-age z scores (P = 0.23 for a global test of differences across groups). Similarly, there were no significant differences in other anthropometric measures, birth outcomes, and morbidity across groups. Adverse events were similar between the groups, except for a higher rate of possible hypercalciuria among the women receiving the highest dose of supplementation.

"In a population with widespread prenatal vitamin D deficiency and fetal and infant growth restriction, maternal vitamin D supplementation from mid-pregnancy until birth or until six months postpartum did not improve fetal or infant growth," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

8 More U.S. Communities to Be Assessed for PFAS Toxin Exposure

8 More U.S. Communities to Be Assessed for ...

Assessments will lay groundwork for future study of the health effects of perfluoroalkyl, polyfluoroalkyl

FDA Advances Regulation to Ensure Sunscreen Safety, Efficacy

FDA Advances Regulation to Ensure Sunscreen Safety, Efficacy

Proposed rule will help consumers better understand what the sunscreens they are buying can actually do

U.S. Agencies Probing Johnson  Johnson Over Asbestos in Talc

U.S. Agencies Probing Johnson & Johnson Over Asbestos ...

Company has faced lawsuits linking its body powders with ovarian cancer or mesothelioma

is free, fast, and customized just for you!




Already a member?

Sign In Now »